combined hemorroid
Conditions
Interventions
Experimental group :Using bupivacaine liposome injection at a dose of 4mg/kg, diluted with physiological saline to a total volume of 30ml, and then injected 5ml layer by layer at each site
control group:20ml of bupivacaine liposome injection was used, diluted with 10ml of physiological saline to a total volume of 30ml, and 5ml was injected layer by layer at each site
Sponsors
Wenjiang District People's Hospital of Chengdu
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1) 18 ~ 65 years old, regardless of sex; Weight <=66.5kg. 2) It meets the relevant diagnostic criteria of mixed hemorrhoids and has clear surgical indications; 3) Subjects voluntarily sign written informed consent;
Exclusion criteria
Exclusion criteria: 1) Patients with serious primary diseases before operation, such as cardiovascular and cerebrovascular diseases, malignant tumors, hematological diseases and abnormal liver and kidney functions; 2) Patients with other anorectal diseases, such as perianal abscess, anal fistula and ulcerative colitis; 3) mental and neurological diseases or severe decline in self-care ability; 4) Those who are known to have allergic history to drugs with similar components and chemical structures in the study drugs or control drugs; 5) Pregnant, quasi-pregnant or lactating women; 6) Other circumstances judged by the researcher as unsuitable for participating in clinical research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Resting state pain score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Anal Edema Score;Anal Control Score;Insomnia score; | — |
Countries
China
Contacts
Public ContactLiu Xu
Wenjiang District People's Hospital of Chengdu
Outcome results
None listed